Budget Impact Comparison of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Cancer Patients Under the Brazilian Private Health Care System Perspective
| Autor: | L. Pititto, E Asano |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Oncology
Gynecology Chemotherapy medicine.medical_specialty business.industry Health Policy medicine.medical_treatment Public Health Environmental and Occupational Health Abiraterone acetate Budget impact Castration resistant medicine.disease chemistry.chemical_compound Prostate cancer chemistry Prednisone Internal medicine Health care Medicine Enzalutamide business medicine.drug |
| Zdroj: | Value in Health. 19:A142 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2016.03.1549 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect